The legacy of Viagra, and its developer copyright, presents a complex case study for investors. Initially a blockbuster drug, generating billions in income, its intellectual property lapse created a flood of https://thebookmarkage.com/story21387671/copyright-s-pill-and-big-pharma-a-uncertain-opportunity